SCHEMBL9595705

SCHEMBL9595705

COc1ccc(Nc2ccc(C)cc2C(=O)O)cc1

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 14/20 0.71
AKR1C2 P52895 14/20 0.71
MEN1 O00255 3/20 0.68
KMT2A Q03164 3/20 0.68
LMNA P02545 2/20 0.68
MAPT P10636 2/20 0.68
POLB P06746 1/20 0.68
CTSV O60911 1/20 0.66
CTSL P07711 1/20 0.66
HPGD P15428 1/20 0.58
GFER P55789 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
DHODH Q02127 2/20 0.57
TP53 P04637 1/20 0.53
GAA P10253 1/20 0.53
MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9593591 0.91 AKR1C3 (0.79) AKR1C3AKR1C2MEN1KMT2ALMNA
SCHEMBL14598926 0.90 AKR1C3 (0.81) AKR1C3AKR1C2MEN1KMT2ALMNA
SCHEMBL8773601 0.90 AKR1C3 (0.81) AKR1C3AKR1C2MEN1KMT2ALMNA
SCHEMBL9593627 0.89 MEN1 (0.83) AKR1C3AKR1C2MEN1KMT2ALMNA
SCHEMBL9594769 0.88 AKR1C3 (0.84) AKR1C3AKR1C2MEN1KMT2ALMNA
SCHEMBL22720143 0.88 MEN1 (0.63) AKR1C3AKR1C2MEN1KMT2ALMNA
SCHEMBL9593414 0.88 AKR1C3 (0.74) AKR1C3AKR1C2MEN1KMT2ALMNA
SCHEMBL1415572 0.86 AKR1C3 (0.82) AKR1C3AKR1C2MEN1KMT2ALMNA
SCHEMBL9594435 0.85 AKR1C3 (0.73) AKR1C3AKR1C2MEN1KMT2ALMNA
SCHEMBL10985308 0.84 MEN1 (0.84) AKR1C3AKR1C2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5229395-A Potential anticancer agents derived from acridine SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-07-20 US disclosed
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 WO disclosed